Tiago Granja1, Jessica Schad2, Patricia Schüssel3, Claudius Fischer4, Helene Häberle5, Peter Rosenberger6, Andreas Straub7. 1. Department of Anaesthesiology and Intensive Care Medicine, Tübingen University Hospital, Eberhard-Karls University Tübingen, Germany. Electronic address: tiago.granja@uni-tuebingen.de. 2. Department of Anaesthesiology and Intensive Care Medicine, Tübingen University Hospital, Eberhard-Karls University Tübingen, Germany. Electronic address: jessica.schad@student.uni-tuebingen.de. 3. Department of Anaesthesiology and Intensive Care Medicine, Tübingen University Hospital, Eberhard-Karls University Tübingen, Germany. Electronic address: patricia.schuessel@student.uni-tuebingen.de. 4. Department of Anaesthesiology and Intensive Care Medicine, Tübingen University Hospital, Eberhard-Karls University Tübingen, Germany. Electronic address: Claudius.Fischer@med.uni-tuebingen.de. 5. Department of Anaesthesiology and Intensive Care Medicine, Tübingen University Hospital, Eberhard-Karls University Tübingen, Germany. Electronic address: Helene.Haeberle@med.uni-tuebingen.de. 6. Department of Anaesthesiology and Intensive Care Medicine, Tübingen University Hospital, Eberhard-Karls University Tübingen, Germany. Electronic address: peter.rosenberger@med.uni-tuebingen.de. 7. Department of Anaesthesiology and Intensive Care Medicine, Tübingen University Hospital, Eberhard-Karls University Tübingen, Germany. Electronic address: andreas.straub@uni-tuebingen.de.
Abstract
INTRODUCTION: Platelets are main effector cells in haemostasis and also promote inflammation. Platelet-leukocyte complexes are key mediators in a variety of thromboinflammatory disorders and consecutive organ failure. Cell-specific epitopes and activation markers on platelets and leukocytes can be measured using flow cytometry. However, until recently a major restriction has been a paucity in antibody combinations and lack of detection strategies. We aimed to develop a six-colour flow cytometry method which depicts multiple aspects of platelet and leukocyte interactions in human whole blood. MATERIALS AND METHODS: Platelets, including microparticles and aggregates, were detected in flow cytometry using a platelet-specific anti-CD41-FITC antibody and size-defined regions. The morphology of platelet-leukocyte complexes (including granulocyte and monocyte content) were depicted using anti-CD45-PerCP, anti-CD66b-PE-Cy7, and anti-CD14-APC antibodies in a single sample. Expression of platelet and leukocyte activation markers P-selectin and CD11b were detected using anti-CD62P-PE and anti-CD11b-BV421 antibodies, respectively. RESULTS: The sensitivity of this assay to detect the effects of various agonists (TRAP-6, ADP, collagen, epinephrine, TNF-α and LPS) is demonstrated. Furthermore, the assay is shown to detect platelet and leukocyte activation induced by extracorporeal circulation in vitro. The suitability of this assay for bedside analysis is demonstrated exemplarily in a patient treated with mechanical circulatory life support. CONCLUSIONS: Using the concurrent assessment of multiple parameters, this method gives detailed insights into the complexity and dynamics of platelet-leukocyte interactions. This assay carries the potential to increase our understanding of the mechanisms and pathophysiology of platelet-leukocyte interaction in the research laboratory and clinical setting.
INTRODUCTION: Platelets are main effector cells in haemostasis and also promote inflammation. Platelet-leukocyte complexes are key mediators in a variety of thromboinflammatory disorders and consecutive organ failure. Cell-specific epitopes and activation markers on platelets and leukocytes can be measured using flow cytometry. However, until recently a major restriction has been a paucity in antibody combinations and lack of detection strategies. We aimed to develop a six-colour flow cytometry method which depicts multiple aspects of platelet and leukocyte interactions in human whole blood. MATERIALS AND METHODS: Platelets, including microparticles and aggregates, were detected in flow cytometry using a platelet-specific anti-CD41-FITC antibody and size-defined regions. The morphology of platelet-leukocyte complexes (including granulocyte and monocyte content) were depicted using anti-CD45-PerCP, anti-CD66b-PE-Cy7, and anti-CD14-APC antibodies in a single sample. Expression of platelet and leukocyte activation markers P-selectin and CD11b were detected using anti-CD62P-PE and anti-CD11b-BV421 antibodies, respectively. RESULTS: The sensitivity of this assay to detect the effects of various agonists (TRAP-6, ADP, collagen, epinephrine, TNF-α and LPS) is demonstrated. Furthermore, the assay is shown to detect platelet and leukocyte activation induced by extracorporeal circulation in vitro. The suitability of this assay for bedside analysis is demonstrated exemplarily in a patient treated with mechanical circulatory life support. CONCLUSIONS: Using the concurrent assessment of multiple parameters, this method gives detailed insights into the complexity and dynamics of platelet-leukocyte interactions. This assay carries the potential to increase our understanding of the mechanisms and pathophysiology of platelet-leukocyte interaction in the research laboratory and clinical setting.
Authors: Natalie M Hohos; Kevin Lee; Lexiang Ji; Miao Yu; Muthugapatti M Kandasamy; Bradley G Phillips; Clifton A Baile; Chuan He; Robert J Schmitz; Richard B Meagher Journal: J Immunol Methods Date: 2016-05-06 Impact factor: 2.303
Authors: Michaela Finsterbusch; Waltraud C Schrottmaier; Julia B Kral-Pointner; Manuel Salzmann; Alice Assinger Journal: Platelets Date: 2018-02-20 Impact factor: 3.862
Authors: Kinga Pluta; Kinga Porębska; Tomasz Urbanowicz; Aleksandra Gąsecka; Anna Olasińska-Wiśniewska; Radosław Targoński; Aleksandra Krasińska; Krzysztof J Filipiak; Marek Jemielity; Zbigniew Krasiński Journal: Biology (Basel) Date: 2022-01-30